Kahn points also to three others that are efficient nasal peptides: the peptide VIP (vasoactive intestinal peptide), which is meant to reduce systemic inflammation, support the gut, and help with brain health and focus
However, both substances affect metabolic and oxidative stress pathways, making informed provider guidance essential before starting either therapy
Im hopeful that with continued use, these benefits will only improve
DISEASES OF THE EYE AND ADNEXA (H52.2 H54.2X21) H52.2 Astigmatism H52.20 Unspecified astigmatism 5th H52.201 Unspecified astigmatism, right eye 6th H52.202 Unspecified astigmatism, left eye H52.203 Unspecified astigmatism, bilateral H52.21 Irregular astigmatism H52.211 Irregular astigmatism, right eye 6th H52.212 Irregular astigmatism, left eye H52.213 Irregular astigmatism, bilateral H52.22 Regular astigmatism H52.221 Regular astigmatism, right eye 6th H52.222 Regular astigmatism, left eye H52.223 Regular astigmatism, bilateral H52.3 Anisometropia and aniseikonia H52.31 Anisometropia 5th H52.32 Aniseikonia H52.4 Presbyopia H52.5 Disorders of accommodation H52.51 Internal ophthalmoplegia (complete) (total) 5th H52.511 Internal ophthalmoplegia (complete) 6th (total), right eye H52.512 Internal ophthalmoplegia (complete) (total), left eye H52.513 Internal ophthalmoplegia (complete) (total), bilateral H52.52 Paresis of accommodation H52.521 Paresis of accommodation, right eye 6th H52.522 Paresis of accommodation, left eye H52.523 Paresis of accommodation, bilateral H52.53 Spasm of accommodation H52.531 Spasm of accommodation, right eye 6th H52.532 Spasm of accommodation, left eye H52.533 Spasm of accommodation, bilateral H52.6 Other disorders of refraction H52.7 Unspecified disorder of refraction (H00 H59) Excludes1Not coded here, do not use together Excludes2Not included here 191 8/16/18 5:33 PM TABULAR LIST H54.3 H54.4 CHAPTER 7
